Synthesis and Distribution of Drugs of Abuse and Related Compounds

The National Institute on Drug Abuse (NIDA) intends to modify the Single Award Indefinite Delivery, Indefinite Quantity (IDIQ) Contract No. 75N95022D00016 to increase the Single Award IDIQ maximum by $3,718,289. The contract provides support services in the areas of producing and distributing labeled and unlabeled drugs of abuse and other research compounds, analyzing and testing the purity of these compounds, replenishing existing drug supply inventory, and maintaining the NIDA drug supply database. The contract has an ordering period of June 9, 2022 to June 8, 2027. Some key aspects of this opportunity include: • Producing and distributing labeled and unlabeled drugs of abuse and other research compounds • Analyzing, testing, and maintaining the purity of drugs of abuse and other chemical compounds • Replenishing existing drug supply inventory with synthesis or acquisition of depleted drug/chemical substances • Identifying, acquiring, storing, and updating the drug supply inventory with newly discovered chemical compounds • Maintaining and updating the NIDA drug supply database